咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Effects of liraglutide and dap... 收藏
Effects of liraglutide and dapagliflozin on bone mineral den...

Effects of liraglutide and dapagliflozin on bone mineral density and bone turnover markers in post menopausal overweight/obese type 2 diabetes mellitus

作     者:Zhong Xing Yang Lina Ye Yongjian Pan Tianrong 

作者单位:Department of Endocrinology The Second Affiliated Hospital of Anhui Medical University 

会议名称:《第十二次全国中西医结合内分泌代谢病学术大会暨糖尿病、甲状腺疾病高峰论坛》

会议日期:2019年

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

关 键 词:CTX Effects of liraglutide and dapagliflozin on bone mineral density and bone turnover markers in post menopausal overweight/obese type 2 diabetes mellitus BMD FPG 

摘      要:Objective To observe the effects of liraglutide and dapagliflozin on bone mineral density and bone turnover markers in postmenopausal overwei ght/obese type 2 diabetes mellitus(T2DM).Methods Sixty-three cases of post menopausal overweight/obese T2DM were randomly divided into liraglutide group(n=32) and dapagliflozin group(n=31).The levels of blood sugar,total cho lesterol(TC),low density lipoprotein(LDL-C),bone mineral density(BMD),type I collagen C-terminal peptide cross-linking(β-CTX),type 1 collagen N-ter minal pro-peptide(P1NP) and alkaline phosphatase(AKP) were compared befor e treatment and 26 weeks after *** *** with baseline,BMI,FPG,HbA1c,TG,TCH and LDL in liraglutide group and dapagliflozin group decreased significantly after 26 weeks of treatment(P0.05).*** with baseli ne,P1 NP in liraglutide group increased significantly after treatment(P0.05),beta-CTX decreased significantly(P0.05),and beta-CTX in dapagliflozin gr oup increased significantly after treatment(P0.05).After treatment,L2-4 B MD was significantly lower in the dapagliflozin group than that in the liragluti de group(P0.05);β-CTX was significantly higher in the dapagliflozin grou p than that in the liraglutide group(P0.05);and P1NP was significantly lo wer than that in the liraglutide group(P0.05).Conclusion Liraglutide and d apagliflozin,two drugs with both hypoglycemic and weight-reducing effects,ha ve no significant improvement on BMD in bone metabolism,However,liragluti de can inhibit bone resorption and promote bone formation,while dapagliflozin can promote bone resorption.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分